XML 38 R7.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Millions
Total IBM Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Total IBM Stockholders' Equity
Common Stock and Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Non-Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at the Beginning of the Period at Dec. 31, 2017   $ 17,594 $ 54,566   $ 153,126 $ (163,507) $ (2,422) $ (26,592) $ 131   $ 17,725
Net income plus other comprehensive income/(loss):                      
Net income   8,728     8,728           8,728
Other comprehensive income/(loss)   (476)           (476)     (476)
Total comprehensive income/(loss)   8,252                 8,252
Cash dividends paid - common stock   (5,666)     (5,666)           (5,666)
Common stock issued under employee plans   585 585               585
Purchases and sales of treasury stock under employee plans - net   (103)     15 (117)         (103)
Other treasury shares purchased, not retired   (4,447)       (4,447)         (4,447)
Changes in other equity   0 0   0           0
Changes in noncontrolling interests                 3   3
Balance at the End of the Period (Accounting Standards Update 2014-09, Revenue from Contracts with Customers) at Dec. 31, 2018 $ 580     $ 580           $ 580  
Balance at the End of the Period (Accounting Standards Updates 2016-01 (Financial Instruments), 2017-12 (Hedging) and 2018-02 (Stranded Tax Effects)) at Dec. 31, 2018       2,422     $ (2,422)        
Balance at the End of the Period at Dec. 31, 2018   16,796 55,151   159,206 (168,071)   (29,490) 134   16,929
Net income plus other comprehensive income/(loss):                      
Net income   9,431     9,431           9,431
Other comprehensive income/(loss)   893           893     893
Total comprehensive income/(loss)   10,324                 10,324
Cash dividends paid - common stock   (5,707)     (5,707)           (5,707)
Common stock issued under employee plans   745 745               745
Purchases and sales of treasury stock under employee plans - net   19     30 (11)         19
Other treasury shares purchased, not retired   (1,331)       (1,331)         (1,331)
Changes in other equity   (5)     (5)           (5)
Changes in noncontrolling interests                 10   10
Balance at the End of the Period at Dec. 31, 2019   20,841 55,895   162,954 (169,413)   (28,597) 144   20,985
Net income plus other comprehensive income/(loss):                      
Net income   5,590     5,590           5,590
Other comprehensive income/(loss)   (740)           (740)     (740)
Total comprehensive income/(loss)   4,850                 4,850
Cash dividends paid - common stock   (5,797)     (5,797)           (5,797)
Common stock issued under employee plans   661 661               661
Purchases and sales of treasury stock under employee plans - net   110     36 74         110
Changes in noncontrolling interests                 (15)   (15)
Balance at the End of the Period at Dec. 31, 2020 $ (66) $ 20,597 $ 56,556 $ (66) $ 162,717 $ (169,339)   $ (29,337) $ 129 $ (66) $ 20,727